A Tampa, Florida-based non-profit dedicated to recovering and transplanting human tissues and a Sarasota, Florida-based manufacturer and distributor of implants and medical instruments, have announced a new distribution partnership.
LifeLink Tissue Bank and Parcus Medical Announce Partnership
1 min read Premium comments
#parcusmedicalSecondary#allograft#lifelinktissuetank
Founded in 1985, LifeLink Tissue Bank of Tampa, Florida is a division of LifeLink Foundation, Inc. that is committed to serving patients in need of transplantation therapy. The LifeLink Foundation is an independent, non-profit community service organization that is comprised of five separate divisions. The LifeLink Tissue Bank’s purpose is to recover and process tissues for patients in need. LifeLink of Florida, LifeLink of Georgia, and LifeLink of Puerto Rico are federally-certified organ procurement organizations. LifeLink Transplantation Immunology Laboratory supports 15 organ transplant programs.
Parcus Medical, LLC, which is headquartered in Sarasota, Florida, designs, manufactures, and distributes implants and medical instruments that are used by orthopedic surgeons to repair shoulder, knee, hip, and distal extremities. Parcus Medical has over 400 different products, which are used in over 60 countries around the world. Parcus Medical is best known for its button fixation system, suture anchors, tenodesis system, graft fixation systems, and interference screws.
Prior to the partnership, Parcus Medical focused largely on addressing sports medicine-related allograft needs. As part of the partnership, Parcus Medical will have access to all allografts in LifeLink Tissue Bank’s current portfolio for all future allograft needs—expanding Parcus Medical’s work in the allograft field beyond sports medicine only. The goal of the partnership is to better serve patients who are in need of tissue transplantation therapy.
Bart Bracy, senior vice president for Parcus Medical, said of the partnership, “Together, we will offer the orthopedic community first-class allograft tissue, implants and instrumentation for sports medicine procedures.”
Michael Consilvio, executive director/general manager for LifeLink Tissue Bank, said, “This synergistic relationship will help patients return to active healthy lifestyles and further increase donation opportunities for donors and their families.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.